Chronicle Journal: Finance

Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Gilead Sciences (NQ: GILD)
72.30 USD  -0.36 (-0.50%)
Streaming Delayed Price  /  Updated: 6:31 AM EST, Feb 28, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 48,009
Open 72.66
Bid (Size) 72.27 (2)
Ask (Size) 72.55 (3)
Prev. Close 72.66
Today's Range 72.30 - 73.71
52wk Range 60.89 - 78.88
Shares Outstanding 1,300,260,832
Dividend Yield 3.08%
Performance
YTD
+10.84%
+10.84%
1 Month
+12.34%
+12.34%
3 Month
+7.53%
+7.53%
6 Month
+13.41%
+13.41%
1 Year
+10.26%
+10.26%
Top News
More News
Gilead Sciences Initiates Two Phase 3 Studies of Investigational Antiviral Remdesivir for the Treatment of COVID-19
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the initiation of two Phase 3 clinical studies to evaluate the safety and efficacy of remdesivir in adults diagnosed with COVID-19 (novel... Read More
from Business Wire News Releases
Noteworthy Thursday Option Activity: SAIA, GILD, MA
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Saia Inc (SAIA), where a total of 4,007 contracts have traded so far, representing... Read More
category Stocks
from Market News Video
More News
Read More
Major bank economist says the coronavirus market reaction ‘boggles the mind’
category BYND , YM00 , NQ00 , and 13 more.
from MarketWatch
April 9th Options Now Available For Gilead Sciences (GILD)
category Stocks
from Market News Video
S&P 500 Movers: FLIR, PWR
category Stocks
from Market News Video
Just Four S&P 500 Stocks Up This Week
category Stocks / Equities
from Blogs - TalkMarkets
US STOCKS-Futures slump on alarm over fast-spreading virus
category companyNews
from Reuters: Company News
Gilead Starts Two Phase III Trials of Remdesivir for COVID-19
from ChinaBio® Today
Why Inovio Pharmaceuticals, Gilead Sciences, Moderna, and Novavax Are All Jumping Today
category NVAX , MRNA , Market News , and 2 more.
from Motley Fool
Gilead Starts Two Phase III Trials of Remdesivir for COVID-19
from ChinaBio® Today
PRESS DIGEST- New York Times business news - Feb. 27
category companyNews
from Reuters: Company News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]